JP2025524914A5 - - Google Patents
Info
- Publication number
- JP2025524914A5 JP2025524914A5 JP2025504039A JP2025504039A JP2025524914A5 JP 2025524914 A5 JP2025524914 A5 JP 2025524914A5 JP 2025504039 A JP2025504039 A JP 2025504039A JP 2025504039 A JP2025504039 A JP 2025504039A JP 2025524914 A5 JP2025524914 A5 JP 2025524914A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- deuterated form
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263369750P | 2022-07-28 | 2022-07-28 | |
| US63/369,750 | 2022-07-28 | ||
| US202363465517P | 2023-05-10 | 2023-05-10 | |
| US63/465,517 | 2023-05-10 | ||
| US202363468978P | 2023-05-25 | 2023-05-25 | |
| US63/468,978 | 2023-05-25 | ||
| PCT/US2023/071162 WO2024026433A2 (en) | 2022-07-28 | 2023-07-27 | Novel dpp1 inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025524914A JP2025524914A (ja) | 2025-08-01 |
| JP2025524914A5 true JP2025524914A5 (enExample) | 2026-05-18 |
Family
ID=89707335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025504039A Pending JP2025524914A (ja) | 2022-07-28 | 2023-07-27 | 新規のｄｐｐ１阻害剤及びその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20260062420A1 (enExample) |
| EP (1) | EP4561565A2 (enExample) |
| JP (1) | JP2025524914A (enExample) |
| WO (1) | WO2024026433A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024009995A (es) * | 2022-02-16 | 2024-08-22 | Insmed Inc | Determinadas n-(1-ciano-2-feniletil)-1,4-oxazepano-2-carboxamidas para el tratamiento de la hidrosadenitis supurativa. |
| EP4484423A4 (en) * | 2022-02-22 | 2026-01-07 | Haisco Pharmaceuticals Pte Ltd | PROCESS FOR PREPARING A HETEROCYCLIC COMPOUND CONTAINING NITROGEN |
| CN115785083A (zh) * | 2022-12-27 | 2023-03-14 | 瑞石生物医药有限公司 | 一种组织蛋白酶c小分子抑制剂及其制备方法 |
| EP4646265A1 (en) | 2023-01-06 | 2025-11-12 | Insmed Incorporated | Novel, reversible dpp1 inhibitors and uses thereof |
| WO2024173556A2 (en) * | 2023-02-15 | 2024-08-22 | Insmed Incorporated | Uses of certain 1,4-oxazepane-2-carboxamides as dpp1 inhibitors |
| EP4680247A1 (en) * | 2023-03-16 | 2026-01-21 | Insmed Incorporated | Dpp1 inhibitors with polycyclic linkers and uses thereof |
| WO2025056038A1 (en) * | 2023-09-15 | 2025-03-20 | Insmed Incorporated | Dipeptidyl peptidase 1 inhibitors and uses thereof |
| WO2025162472A1 (en) * | 2024-01-31 | 2025-08-07 | Insmed Incorporated | Linear dipeptidyl peptidase 1 inhibitors and uses thereof |
| WO2025167969A1 (en) * | 2024-02-07 | 2025-08-14 | Insmed Incorporated | Dipeptidyl peptidase 1 inhibitors and uses thereof |
| WO2025214073A1 (en) * | 2024-04-12 | 2025-10-16 | Insmed Incorporated | Dipeptidyl peptidase 1 inhibitors and uses thereof |
| WO2025250560A1 (en) * | 2024-05-28 | 2025-12-04 | Insmed Incorporated | Methods for treating bronchiectasis |
| CN118666833B (zh) * | 2024-05-30 | 2024-12-13 | 龙曦宁（上海）医药科技有限公司 | 一种2-（5-溴吡啶-3-基）奎宁环的制备方法 |
| WO2026083346A1 (en) * | 2024-10-18 | 2026-04-23 | Insmed Incorporated | Dpp1 inhibitors with cyclic or linear linkers and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100098683A (ko) * | 2007-12-12 | 2010-09-08 | 아스트라제네카 아베 | 펩티딜 니트릴, 및 디펩티딜 펩티다제 ｉ 억제제로서의 그의 용도 |
| WO2011154677A1 (en) * | 2010-06-09 | 2011-12-15 | Astrazeneca Ab | Substituted n-[1-cyano-2-(phenyl)ethyl] 1-aminocycloalk-1-ylcarboxamide compounds - 760 |
-
2023
- 2023-07-27 JP JP2025504039A patent/JP2025524914A/ja active Pending
- 2023-07-27 US US18/997,734 patent/US20260062420A1/en active Pending
- 2023-07-27 EP EP23847581.8A patent/EP4561565A2/en active Pending
- 2023-07-27 WO PCT/US2023/071162 patent/WO2024026433A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024508755A5 (enExample) | ||
| JP2020169171A5 (enExample) | ||
| JP2023527575A5 (enExample) | ||
| JP2022522694A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2005533835A5 (enExample) | ||
| JP2020533352A5 (enExample) | ||
| JP2023500611A5 (enExample) | ||
| JP2020505405A5 (enExample) | ||
| JP2005523922A5 (enExample) | ||
| JP2006182786A5 (enExample) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP2005511699A5 (enExample) | ||
| JPH0222066B2 (enExample) | ||
| JP2022541545A5 (enExample) | ||
| JP2007504235A5 (enExample) | ||
| JP2025505200A5 (enExample) | ||
| JP2025509438A5 (enExample) | ||
| JP2005517677A5 (enExample) | ||
| JP2023513793A5 (enExample) | ||
| JP2006524227A5 (enExample) | ||
| RU96109699A (ru) | Гуанидиды алкенилкарбоновых кислот, способ их получения, содержащее их лекарственное или диагностическое средство, способ его получения, способ лечения и профилактики сердечных заболеваний | |
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| JP2025118775A5 (enExample) | ||
| JP2020519659A5 (enExample) |